Journal of Contemporary Brachytherapy
eISSN: 2081-2841
ISSN: 1689-832X
Journal of Contemporary Brachytherapy
Current Issue Archive Supplements Articles in Press Journal Information Aims and Scope Editorial Office Editorial Board Register as Author Register as Reviewer Instructions for Authors Abstracting and indexing Subscription Advertising Information Links
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank

5/2025
vol. 17
 
Share:
Share:
abstract:
Original paper

Hybrid inverse treatment planning optimization in gynecologic brachytherapy: Comparison with conventional method

Hiroyuki Okamoto
1
,
Masato Nishitani
1, 2
,
Ayaka Nagao
3, 4
,
Naoya Murakami
5
,
Noriyuki Okonogi
5
,
Jun Takatsu
5
,
Kotaro Ijima
3, 5
,
Satoshi Nakamura
1
,
Takahito Chiba
1
,
Hiroki Nakayama
1
,
Tetsu Nakaichi
1
,
Takumi Sakamoto
1, 6
,
Kae Okuma
3
,
Hiroshi Igaki
3
,
Daisuke Ozaki
7
,
Ken Ando
8
,
Tatsuya Ohno
8

  1. Radiation Safety and Quality Assurance Division, National Cancer Center Hospital, Tokyo 104-0045, Japan
  2. Department of Radiological Sciences, Graduate School of Human Health Sciences, Tokyo Metropolitan University, Tokyo 116-8551, Japan
  3. Department of Radiation Oncology, National Cancer Center Hospital, Tokyo 104-0045, Japan
  4. Cancer Medicine, Cooperative Graduate School, Jikei University Graduate School of Medicine, Tokyo, 105-8461, Japan
  5. Department of Radiation Oncology, Juntendo University Graduate School of Medicine, Tokyo 113-8431, Japan
  6. Department of Radiological Sciences, Komazawa University, Tokyo 154-8525, Japan
  7. Department of Radiology, Gunma University Hospital, Gunma 371-8511, Japan
  8. Department of Radiation Oncology, Gunma University Graduate School of Medicine, Gunma 371-8511, Japan
J Contemp Brachytherapy 2025; 17, 5: 340–353
Online publish date: 2025/10/31
View full text Get citation
 
Purpose
To investigate a semi-automatic hybrid inverse treatment planning optimization (HIPO) approach for gynecological brachytherapy that preserves the pear-shaped dose distribution without relying on dummy structures.

Material and methods
We retrospectively analyzed 29 patients with gynecological cancers, who underwent combined intracavitary and interstitial (IC/IS) brachytherapy. HIPO enables optimization of dwell times for specific applicators, while other applicators are fixed in Oncentra® Brachy. Clinical treatment plans (CPs) were compared based on manual adjustments using four HIPO methods: Hovoid, Hfree, HMS, and HMS*. Hovoid optimized tandem and IS needles with ovoid dwell time fixed; Hfree optimized all applicators with no fixation; HMS optimized IS needles with fixation using modified Manchester system, with safe organs at risks (OARs) doses generated in advance by graphical optimization. In HMS* plan, optimization parameters were adjusted to improve high-risk clinical target volume (HR-CTV) dose coverages based on comparisons between CPs and HMS.

Results
Hovoid, Hfree, HMS, and HMS* achieved clinically acceptable DVH parameters in terms of HR-CTV dose coverage and OARs sparing. However, considerable deviations from the conventional pear-shaped dose distributions were observed, particularly with Hfree, which exhibited zero dose contribution from ovoid applicators. Among all HIPO plans, HMS* with adjusted optimization parameters demonstrated the closest HR-CTV D90% to that of the CP, while maintaining a conventional pear-shaped dose distribution.

Conclusions
We recommend applying the modified Manchester system with safe OARs doses as the object of fixation, given its consistency with the conventional pear-shaped dose distribution. The proposed method demonstrated clinically acceptable dose distribution and DVH parameters.

keywords:

inverse planning, HIPO, gynecologic brachytherapy, IC/IS, Manchester system

 
Quick links
© 2025 Termedia Sp. z o.o.
Developed by Bentus.